Distribution of micafungin in the tissue fluids of patients with invasive fungal infections
Authors:
- Keisuke KumadaKKKeisuke Kumada
- Shinji OguraSOShinji Ogura
- Satoshi KishinoSKSatoshi Kishino
- Nobuo MochizukiNMNobuo Mochizuki
- Keiko OhnoKOKeiko Ohno
- 1 January 2011
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 17 (5) , 731-734
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disordersLeukemia & Lymphoma, 2009
- Ocular distribution of intravenously administered micafungin in rabbitsJournal of Infection and Chemotherapy, 2008
- MicafunginDrugs, 2008
- Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialThe Lancet, 2007
- A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasisAlimentary Pharmacology & Therapeutics, 2005
- National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafunginJournal of Antimicrobial Chemotherapy, 2004
- Tissue Distribution after Intravenous Dosing of Micafungin, an Antifungal Drug, to RatsBiological and Pharmaceutical Bulletin, 2004
- Antifungal Mechanism of FK463 against Candida albicans and Aspergillus fumigatus.The Journal of Antibiotics, 2002
- Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in RabbitsAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important FungiAntimicrobial Agents and Chemotherapy, 2000